ArticleJournal of patient-reported outcomes2020

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.

Michael Herdman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.